Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Peak Bio, Inc. Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing January 04, 2024 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing September 19, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Announces Up-listing to OTCQB Market August 31, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors August 31, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market August 29, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital August 24, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting August 23, 2023 From Peak Bio, Inc. Via GlobeNewswire Tickers PKBO Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital November 04, 2022 From Peak Bio, Inc. Via Business Wire Tickers PKBO Peak Bio Co., Ltd. to List on NASDAQ Following Successful Business Combination with Ignyte Acquisition Corp. November 02, 2022 From Peak Bio, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
